Alternative Cre drivers, such as Periostin [71] or Nfatc1 [72], that target VICs at different developmental time points, including cells not derived from the Tie2 lineage, may further clarify the contributions of RB1 to aortic valve disease. This evidence concerns the gene TEK and aortic valve disorder.